The Current Suspension/Debarment Landscape

Client Alert | less than 1 min read | 05.25.17

With the federal suspension/debarment processes becoming more collaborative, contractors find themselves facing new agencies and new (and, generally, longer-lasting) procedures when dealing with suspending and debarring officials. David Robbins, Angela Styles & Peter Eyre cover the most recent changes in federal suspension, debarment, and proactive disclosure practice in Not Your Grandfather’s Suspension & Debarment: How Contractors Can Prepare For and Defend Against Today’s Exclusions.

Contacts

Peter Eyre
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2807
cGV5cmVAY3Jvd2VsbC5jb20=

Insights

Client Alert | 3 min read | 03.02.26

Changes to UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions of UK Model Clinical Trial Agreement Forms Pending.

Clinical trial sponsors and all other stakeholders involved in conducting commercial clinical trials of investigational medicinal products (IMP) in the UK....

Client Alert | 4 min read | 03.02.26
Ex parte Reexamination: Strategic Considerations for Patent Challengers in Light of Recent PTAB Policy Changes
Client Alert | 3 min read | 02.27.26
EEOC v. Coca-Cola Beverages Northeast, Inc.: Another Step Focused on the EEOC’s Goal of Eradicating Unlawful DEI-Related Practices
Client Alert | 6 min read | 02.27.26
Major Questions, Major Drama

View All Insights